I am a 4th year Cancer Biology PhD candidate in the Bassik and Greenleaf labs at Stanford. I’m interested in the intersection between technology development, epigenetics, and tumor immunology. At Stanford, I study how macrophage state and function changes upon cancer cell phagocytosis during mAb treatment. This work can help us understand the regulators that drive dysfunctional macrophage states in cancer.

In my undergrad at Columbia University, I studied environmental science and biology—I’ve always been interested in how to transform scientific advancements into tangible action, whether through climate policy or therapeutics in biotech. I’ve worked on a wide range of problems from measuring background gamma radiation following nuclear weapons testing to developing better in vitro models to study tumor invasion. Following my undergrad, I worked in the Regev and Lander labs at the Broad Institute of Harvard and MIT to build a screening platform for human transcription factor domains to develop better tools for genetic engineering. Outside of research, I love live music, doing ceramics, and playing tennis.

‍

WHAT IS A HEALTHCARE ADVANCEMENT YOU HOPE TO SEE IN YOUR LIFETIME?

Increased accessibility of early cancer diagnostics and personalized cancer treatment.

‍

WHAT EXCITES YOU MOST ABOUT TECHBIO?

I am most excited by TechBio's potential to increase the pace of scientific progress. TechBio will enable the development of tools that leverage the availability of multiomics data to accelerate drug discovery, design de novo proteins for genome engineering, and bring therapeutics to the clinic faster.

‍

WHAT IS THE MOST INFLUENTIAL CONTENT YOU READ LAST YEAR?

Trick Mirror by Jia Tolentino. A thought-provoking collection of essays on how our self-perception is shaped by the rise of internet culture.